This action arises out of Lupin's filing of an Abbreviated New Drug Application("ANDA") seeking approval to sell generic copies of Janssen's highly successful PREZISTA® (darunavir) 800 mg tablets prior to the expiration of patents owned by Janssen.
Complaint for Patent Infringement
Civil Action No.2:13-cv-04039, the Hon. William H. Walls presiding.
Filed on June 28, 2013 in the U.S. District Court for the District of New Jersey;
Patent in suit: US 7,470,506 (Expiry:Dec 23, 2019) -claim type: Method of treatment (MOT)
Complaint for Patent Infringement
Civil Action No.2:13-cv-04039, the Hon. William H. Walls presiding.
Filed on June 28, 2013 in the U.S. District Court for the District of New Jersey;
Patent in suit: US 7,470,506 (Expiry:Dec 23, 2019) -claim type: Method of treatment (MOT)